Your browser doesn't support javascript.
loading
Topical treatments for skin cancer.
Cullen, Jason K; Simmons, Jacinta L; Parsons, Peter G; Boyle, Glen M.
Affiliation
  • Cullen JK; Drug Discovery Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; School of Biomedical Sciences Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.
  • Simmons JL; Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia.
  • Parsons PG; Drug Discovery Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; School of Biomedical Sciences Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.
  • Boyle GM; Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; School of Biomedical Sciences Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia; School of Biomedical Sciences, Faculty of Health, Queensland University of Technolog
Adv Drug Deliv Rev ; 153: 54-64, 2020 01 01.
Article in En | MEDLINE | ID: mdl-31705912
Skin cancer is a broad term used to describe a number of different malignant indications of the skin. Skin cancers mostly comprise of the keratinocyte cancers [Basal Cell Carcinoma (BCC) and cutaneous Squamous Cell Carcinoma (SCC)], and melanoma. Surgical excision of these malignancies has been the preferred treatment of patients for decades. However, the decision to perform surgery can be affected by various considerations, including co-morbidities of the patient, the anatomical site of the lesion and potential intolerance for repeated excisions. Topical treatment of skin cancer may therefore be more appropriate in certain instances. Topical treatment potentially allows for higher drug levels at the tumor site, and may result in less overall toxicity than systemic agents. This review will specifically address the current agents used in topical treatment of skin cancers, and introduce emerging treatments from the natural product field that may also find utility in these indications.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Drug Delivery Systems / Antineoplastic Agents Type of study: Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Adv Drug Deliv Rev Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2020 Document type: Article Affiliation country: Australia Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Drug Delivery Systems / Antineoplastic Agents Type of study: Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Adv Drug Deliv Rev Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2020 Document type: Article Affiliation country: Australia Country of publication: Netherlands